Avandia - MSN Newsfeeds
- Washington Post - In addition to casting doubt on notions such as lowering cholesterol to prevent heart disease and normalizing blood sugar to protect diabetics, the studies involving well-known drugs such as Avandia and Vytorin have also rekindled concern about whether ...
- Philadelphia Inquirer - Glaxo's blockbuster diabetes drug Avandia "generated much lower sales" in the second half of 2007 because of safety concerns, S&P noted. In addition, the company's financial profile "will be impaired" by a record share-buyback program that allocates ...
- Washington Post - Avandia, widely used to lower blood sugar levels, appeared to increase the risk of heart attacks, a study found. (By Jb Reed -- Bloomberg News) In addition to casting doubt on notions such as lowering cholesterol to prevent heart disease and ...
- CNBC - In addition, GSK's blockbuster diabetes drug Avandia generated much lower sales in the second half of 2007 owing to concerns about safety. Furthermore, the group's financial profile will be impaired by a record share-buyback program allocating 6 bln ...
- Baltimore Sun - Researchers said they don't know what caused the spike in deaths but said it can't be blamed on Avandia - a diabetes medication linked last year to an increased risk of heart attacks - even though some volunteers were taking the drug. "Clearly we did ...
- Stockhouse Canada - Take, for example, GSK's recent activities in support of Avandia. Following the May 2007 publication of a meta-analysis in the New England Journal of Medicine concluding that Avandia increases cardiovascular (CV) risk, the company had to quickly and ...
- The Independent - The company issued a profit warning last week, blaming safety concerns that are crimping sales of the diabetes drug Avandia. However, departing chief executive Jean-Pierre Garnier made an upbeat pitch to long-term investors, saying the company's ...
- Financial Times - ... shares have recently been hit after Jean-Pierre Garnier, GSK’s outgoing chief executive, warned last week of a single mid-digit decline in earnings during 2008 on the back of increasing generic competition and sluggish performance on Avandia, its ...
- Palm Beach Interactive - After problems linked to Vioxx, Avandia and other drugs, patients are more reticent to take a new script. — Fewer new drugs on the market. The Food and Drug Administration approved only 18 new medicines last year, fewest in many years. — Higher ...
- Raleigh News & Observer - A study links diabetes pill Avandia to higher heart attack risk. Sales drop. Mid-2007: Two new AIDS drugs start to grab market share from Combivir. August 2007: GSK fails to win FDA approval for an added use for Advair that would have expanded sales ...
- Raleigh News & Observer - A study links diabetes pill Avandia to higher heart attack risk. Sales drop. Mid-2007: Two new AIDS drugs start to grab market share from Combivir. August 2007: GSK fails to win FDA approval for an added use for Advair that would have expanded sales ...
- Reuters UK - GSK shares have been battered in recent sessions after Europe's biggest drugmaker warned that 2008 earnings would fall due to sliding sales of diabetes drug Avandia and more generic competition. Shares in Anglo-Swedish drugmaker AstraZeneca have also ...
- Globe and Mail - Some patients took up to five shots of insulin a day, along with medications to lower blood pressure and cholesterol, as well as drugs to control blood sugar such as Avandia - a diabetes drug that has been in the news a lot because it appears to ...
- Wired News - And a close look at the multiple medications patients used, including the drug Avandia that is suspected of being heart-risky, showed no sign that any were to blame. Ironically, the study's death rate was well below what doctors usually see in Type 2 ...
- Fox 6 - Side Effects of Avandia 8/8/07 Some studies have linked Avandia to heart attacks and kidney failure, but despite some critics the FDA has voted in favor of keeping the diabetes drug on the market. Dr Alan Conrad, director of the diabetes program at ...
- MSN MoneyCentral - Attorneys for Grove residents Pat and Sandra Kelly allege in the lawsuit that the drugmaker should have known that Avandia was associated with a significant increased risk of heart failure, heart attack and stroke, among other side effects. The ...
- CNBC - Attorneys for Grove residents Pat and Sandra Kelly allege in the lawsuit that the drugmaker should have known that Avandia was associated with a significant increased risk of heart failure, heart attack and stroke, among other side effects. The ...
- New England Journal of Medicine - Many respondents opined that recent reports suggesting that rosiglitazone may be associated with increased cardiovascular risk 2 , 3 do not apply to pioglitazone, whereas several respondents who voted for other treatment options expressed concern that such ...
- Wall Street Journal - Glaxo, for example, last week forecast an earnings decline this year because of generic competition and lower sales of the diabetes pill Avandia. Sanofi is benefiting from a recovery in sales of anticlotting drug Plavix, which plummeted in 2006 when ...
- Boston Globe - Attorneys for Grove residents Pat and Sandra Kelly allege in the lawsuit that the drugmaker should have known that Avandia was associated with a significant increased risk of heart failure, heart attack and stroke, among other side effects. The ...
Want to contact an Avandia attorney in Washington, DC?...Get a free case evaluation from one of our Avandia attorneys in Washington, DC now.
Pages: 1 2 3 4 5 6 ... Next
This form is secure and encrypted. More information about secure forms and your privacy here.
Avandia Case Evaluation Form
